TAMPROS-F TABLETS
TAMPROS-F TABLETS
Product Details :
| Feature | Details |
|---|---|
| Product Name | TAMPROS-F Tablets |
| Form | Tablets |
| Key Ingredients | Tamsulosin Hydrochloride 0.4 mg + Finasteride 5 mg |
| Core Benefits | Improves urine flow and reduces prostate size |
| Mechanism of Action | Alpha-1 blocker + 5-alpha reductase inhibitor |
| Support Areas | Benign Prostatic Hyperplasia (BPH), urinary retention |
| Recommended Usage | 1 tablet daily after a meal or as prescribed by a physician |
| Target Audience | Adult males with enlarged prostate |
| Packaging Type | Blister pack |
Composition: Tamsulosin 0.4 mod. Rel. + finasteride 5mg Packing: 10X10 Alu-Alu
Description : TAMPROS-F Tablets combine Tamsulosin Hydrochloride (0.4 mg) and Finasteride (5 mg), a dual-action therapy for Benign Prostatic Hyperplasia (BPH). Tamsulosin relaxes the muscles of the prostate and bladder neck to improve urine flow, while Finasteride shrinks the enlarged prostate by inhibiting the conversion of testosterone. This combination reduces urinary retention, nocturia, and urgency, while slowing disease progression. TAMPROS-F offers a long-term solution to BPH symptoms and is recommended under urological supervision for optimal prostate health.